cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Lucid Diagnostics Inc
3 own
10 watching
Current Price
$0
$0.01
(0.77%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
48.31M
52-Week High
52-Week High
4.0598
52-Week Low
52-Week Low
1.105
Average Volume
Average Volume
0.08M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization48.31M
icon52-Week High4.0598
icon52-Week Low1.105
iconAverage Volume0.08M
iconDividend Yield--
iconP/E Ratio--
What does the Lucid Diagnostics Inc do?
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, a esophageal cell collection device. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.
Read More
How much money does Lucid Diagnostics Inc make?
News & Events about Lucid Diagnostics Inc.
Business Wire
23days ago
PAVmed Inc. (Nasdaq: PAVM, PAVMZ), a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors, and its majority-owned subsidiaries Lucid Diagnostics Inc. (Nasdaq: LUCD), a commercial-stage cancer prevention diagnostics company...
Business Wire
1month ago
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (PAVmed), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it has entered into a license option and joint research and development agreement with Novosound Ltd...
Business Wire
1month ago
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (PAVmed), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that its majority-owned digital health subsidiary Veris Health Inc. (Veris), has commercially launched its...
Zolmax
1month ago
Shares of Lucid Diagnostics Inc. (NASDAQ:LUCD Get Rating) have been given a consensus recommendation of Buy by the six analysts that are covering the stock, Marketbeat.com reports. Four analysts have rated the stock with a buy recommendation. The average twelve-month price target among analysts that...
Business Wire
2 months ago
Lucid Diagnostics Inc. (Nasdaq: LUCD) (Lucid), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (PAVmed), today announced that Suman M. Verma, M.D., Ph.D., Lucids Chief Scientific Officer, presented real-world data...
Frequently Asked Questions
Frequently Asked Questions
What is Lucid Diagnostics Inc share price today?
plus_minus_icon
Can Indians buy Lucid Diagnostics Inc shares?
plus_minus_icon
How can I buy Lucid Diagnostics Inc shares from India?
plus_minus_icon
Can Fractional shares of Lucid Diagnostics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Lucid Diagnostics Inc stocks?
plus_minus_icon
What is today’s traded volume of Lucid Diagnostics Inc?
plus_minus_icon
What is today’s market capitalisation of Lucid Diagnostics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Lucid Diagnostics Inc?
plus_minus_icon
What percentage is Lucid Diagnostics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Lucid Diagnostics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0.01
(0.77%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00